Platelet-rich fibrin versus demineralized freeze-dried bone allograft for peri-implant bone regeneration after immediate implant placement: A CBCT study
Bioinformation · 31.10.2026 · 22 (10) · 7638-7642
DOI: 10.6026/973206300227638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.10.2026. Verfasst von Tamim Ahmad.
Abstract (Originalsprache)
Immediate implant placement can reduce treatment time, but the residual peri-implant jumping gap may influence hard-tissue healing. Therefore, it is of interest to compare the platelet-rich fibrin (PRF) with demineralized freeze-dried bone allograft (DFDBA) for management of the jumping gap after immediate implant placement in 30 sites allocated to two groups (n=15 each). CBCT measurements at implant placement and six months assessed horizontal bone thickness, vertical bone height and change in alveolar crest height. Both groups showed peri-implant bone regeneration; however, DFDBA produced significantly greater six-month horizontal bone thickness (p=0.017), vertical bone height (p=0.005) and change in alveolar crest height (p=0.001) than PRF. Thus, DFDBA provided greater preservation or gain of peri-implant hard-tissue dimensions than PRF over six months.
Zitieren
APA
Ahmad, T. (2026). Platelet-rich fibrin versus demineralized freeze-dried bone allograft for peri-implant bone regeneration after immediate implant placement: A CBCT study. Bioinformation, 22(10), 7638-7642. https://doi.org/10.6026/973206300227638
Vancouver
Ahmad T. Platelet-rich fibrin versus demineralized freeze-dried bone allograft for peri-implant bone regeneration after immediate implant placement: A CBCT study. Bioinformation. 2026;22(10):7638-7642. doi:10.6026/973206300227638
BibTeX
@article{Ahmad2026,
author = {Ahmad, Tamim},
title = {Platelet-rich fibrin versus demineralized freeze-dried bone allograft for peri-implant bone regeneration after immediate implant placement: A CBCT study},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {10},
pages = {7638--7642},
doi = {10.6026/973206300227638}
}
EUVIMED